Imputation of a true endpoint from a surrogate: Application to a cluster randomized controlled trial with partial information on the true endpoint

3Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The Anglia Menorrhagia Education Study (AMES) is a randomized controlled trial testing the effectiveness of an education package applied to general practices. Binary data are available from two sources; general practitioner reported referrals to hospital, and referrals to hospital determined by independent audit of the general practices. The former may be regarded as a surrogate for the latter, which is regarded as the true endpoint. Data are only available for the true end point on a sub set of the practices, but there are surrogate data for almost all of the audited practices and for most of the remaining practices. Methods: The aim of this paper was to estimate the treatment effect using data from every practice in the study. Where the true endpoint was not available, it was estimated by three approaches, a regression method, multiple imputation and a full likelihood model. Results: Including the surrogate data in the analysis yielded an estimate of the treatment effect which was more precise than an estimate gained from using the true end point data alone. Conclusions: The full likelihood method provides a new imputation tool at the disposal of trials with surrogate data.

Cite

CITATION STYLE

APA

Nixon, R. M., Duffy, S. W., & Fender, G. R. K. (2003). Imputation of a true endpoint from a surrogate: Application to a cluster randomized controlled trial with partial information on the true endpoint. BMC Medical Research Methodology, 3, 1–11. https://doi.org/10.1186/1471-2288-3-17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free